Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial

Annals of Oncology

Volumn 11, Issue 8, 2000, Pages 999-1006

  Harrison, G ^a   Richards, S ^a   Lawson, S ^b   Darbyshire, P ^b   Pinkerton, R ^c   Stevens, R ^d   Oakhill, A ^e   Eden, O B ^d  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^e BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Allogeneic bone marrow transplant; Childhood; Relapsed ALL

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGRAFT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK; TREATMENT OUTCOME;

EID: 0033807095     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008381801403     Document Type: Article

References (19)

1. Relapsed lymphoblastic leukaemia in children: A continuing challenge
2. Survival after relapse in childhood acute lymphoblastic leukemia: Impact of site and time to first relapse - The Children's Cancer Group Experience
3. Comparison of bone-marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: The MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia
4. Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone-marrow transplantation. Superior survival following transplantation with matched unrelated donor grafts
5. Unrelated donor bone-marrow transplantation for children with relapsed acutelymphoblastic leukaemia in second complete remission
6. Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia
7. Improved survival with early intensification: Combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia
8. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)
9. Acute lymphoblastic leukaemia in infancy: Experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia
10. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: A report on the Medical Research Council UKALL R1 study. MRC Childhood Leuakaemia Working Party
11. How to avoid bias when comparing bone marrow transplantation with chemotherapy
12. Secondary prevention of vascular disease by prolonged antiplatelet treatment
13. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
14. Evaluation of response-time data involving transient states: An illustration using heart transplant data
15. ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone-marrow relapse
16. Acute lymphoblastic leukemia: A comprehensive review with emphasis on biology and therapy
17. Allogeneic bone-marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission; A single institution study
18. Adjusting for non-compliance and contamination in randomized clinical trials